URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Yuhchyau Chen

Concepts (269)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Carcinoma, Non-Small-Cell Lung
12
2001
70
5.020
Why?
Lung Neoplasms
13
2001
435
4.410
Why?
Reticulocytes
8
2003
47
4.250
Why?
Paclitaxel
6
2001
59
2.390
Why?
Micronuclei, Chromosome-Defective
4
2007
21
2.320
Why?
Radiation-Sensitizing Agents
5
2001
74
2.300
Why?
Radiation Pneumonitis
6
2001
43
1.750
Why?
Neoplasms
8
2003
743
1.610
Why?
Gamma Rays
3
2009
69
1.560
Why?
Thoracic Neoplasms
4
2001
20
1.440
Why?
Antineoplastic Agents, Phytogenic
3
2003
37
1.380
Why?
Bone Marrow Cells
2
2009
222
1.350
Why?
Micronucleus Tests
6
2003
25
1.310
Why?
Flow Cytometry
12
1988
603
1.170
Why?
Dose-Response Relationship, Radiation
9
2003
216
1.050
Why?
Fibroblast Growth Factor 7
2
2011
11
1.050
Why?
Radiation Injuries, Experimental
3
2005
89
0.990
Why?
Whole-Body Irradiation
4
1999
87
0.980
Why?
Interleukin-6
4
2001
339
0.870
Why?
Chemoradiotherapy
1
2012
1
0.850
Why?
Radiation Oncology
2
2006
18
0.840
Why?
Deglutition Disorders
1
2012
28
0.830
Why?
Laryngeal Neoplasms
1
2011
19
0.810
Why?
Middle Aged
22
2001
10013
0.800
Why?
Chromosome Aberrations
3
2003
117
0.780
Why?
Taxoids
1
2010
13
0.760
Why?
Radiotherapy
5
2003
198
0.760
Why?
Aged
17
2001
7392
0.760
Why?
Combined Modality Therapy
5
2003
491
0.750
Why?
Aged, 80 and over
12
2001
2588
0.740
Why?
Cell Cycle
9
1988
253
0.730
Why?
Radiometry
1
2010
40
0.730
Why?
Biological Assay
1
2010
69
0.710
Why?
Radiotherapy Dosage
9
2001
202
0.710
Why?
Pneumonectomy
2
2008
14
0.700
Why?
Carcinoma, Squamous Cell
1
2011
238
0.700
Why?
Adult
22
1988
11572
0.690
Why?
Female
27
1988
20222
0.690
Why?
Neoplastic Stem Cells
1
2009
40
0.690
Why?
Palliative Care
2
2010
161
0.670
Why?
Radiation Injuries
3
2006
131
0.670
Why?
Humans
41
1988
37165
0.660
Why?
Male
24
1988
20139
0.640
Why?
Cesium Radioisotopes
1
2007
29
0.620
Why?
Clinical Trials as Topic
2
2004
685
0.620
Why?
Biological Markers
6
2001
564
0.610
Why?
Biomedical Research
1
2009
137
0.600
Why?
Automation
1
2006
32
0.580
Why?
Treatment Outcome
10
2008
2671
0.580
Why?
Interleukin-1
2
2002
221
0.570
Why?
Nuclear Energy
1
2006
3
0.560
Why?
Radiobiology
1
2006
10
0.560
Why?
International Agencies
1
2006
9
0.560
Why?
Cytokines
3
2002
575
0.500
Why?
Dose Fractionation
4
2009
57
0.450
Why?
Mice
11
1990
6206
0.430
Why?
Genetic Testing
1
2003
102
0.430
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2009
436
0.420
Why?
Drug Administration Schedule
3
2001
374
0.420
Why?
Oxygen
1
2005
495
0.410
Why?
Neoplasm Staging
4
2008
354
0.390
Why?
Platelet-Derived Growth Factor
3
1989
114
0.390
Why?
Neoplasms, Experimental
1
2001
149
0.390
Why?
Epidermal Growth Factor
3
1989
115
0.390
Why?
Bioreactors
2
2009
8
0.380
Why?
Genetic Predisposition to Disease
1
2003
317
0.370
Why?
Severity of Illness Index
3
2006
943
0.370
Why?
Somatomedins
2
1989
14
0.370
Why?
Animals
15
1990
16416
0.370
Why?
Follow-Up Studies
4
2001
1889
0.340
Why?
Insulin-Like Growth Factor I
2
1989
106
0.340
Why?
Head and Neck Neoplasms
2
2007
84
0.330
Why?
Retrospective Studies
6
2008
2302
0.320
Why?
Radiosurgery
2
2009
73
0.320
Why?
Cell Survival
2
1990
559
0.320
Why?
Antineoplastic Agents
5
2003
628
0.310
Why?
Cells, Cultured
7
1988
2589
0.310
Why?
Tumor Necrosis Factor-alpha
2
2001
694
0.300
Why?
DNA Damage
4
2003
164
0.300
Why?
Enzyme-Linked Immunosorbent Assay
3
2001
472
0.290
Why?
Mitosis
2
1990
101
0.290
Why?
Fibroblasts
3
1988
545
0.290
Why?
Cisplatin
3
2009
93
0.270
Why?
Survival Rate
4
2009
619
0.270
Why?
Mice, Inbred C57BL
3
2009
1700
0.270
Why?
Tumor Cells, Cultured
3
2001
886
0.260
Why?
Sensitivity and Specificity
2
2005
914
0.240
Why?
Proportional Hazards Models
3
2008
426
0.240
Why?
Tumor Markers, Biological
2
2003
240
0.240
Why?
Pyrazoles
2
2003
59
0.240
Why?
Time Factors
5
1989
3234
0.240
Why?
Tomography, X-Ray Computed
3
2003
785
0.230
Why?
Receptors, Thrombopoietin
1
2012
9
0.220
Why?
Hydrazines
1
2012
14
0.220
Why?
Benzoates
1
2012
16
0.210
Why?
Survival Analysis
2
2011
589
0.210
Why?
Double-Blind Method
2
2011
996
0.210
Why?
Disease Progression
2
2009
533
0.210
Why?
Carboplatin
1
2012
29
0.210
Why?
Skin
2
1989
384
0.210
Why?
Population
1
2011
10
0.210
Why?
Stomatitis
1
2011
16
0.200
Why?
Thrombocytopenia
1
2012
77
0.200
Why?
Disease-Free Survival
1
2012
204
0.200
Why?
SEER Program
1
2011
55
0.200
Why?
Kaplan-Meier Estimate
1
2012
207
0.200
Why?
Culture Media
2
1988
196
0.200
Why?
Recombinant Proteins
2
2010
770
0.190
Why?
Tumor Stem Cell Assay
1
2010
24
0.190
Why?
Erythroid Cells
1
2011
23
0.190
Why?
Stem Cell Transplantation
1
2012
115
0.190
Why?
Bromodeoxyuridine
4
1988
68
0.190
Why?
Magnetic Resonance Spectroscopy
1
1992
242
0.190
Why?
Granulocyte Colony-Stimulating Factor
1
2010
45
0.190
Why?
Nausea
2
2007
155
0.190
Why?
Remission Induction
1
2010
165
0.190
Why?
Erythropoiesis
1
2010
63
0.180
Why?
Translational Medical Research
1
2010
38
0.180
Why?
Neoplasm Recurrence, Local
2
2009
295
0.180
Why?
Cell Line, Tumor
2
2003
576
0.180
Why?
Neoplastic Cells, Circulating
1
2009
7
0.180
Why?
Radiation Dosage
1
2010
122
0.180
Why?
Information Dissemination
1
2009
24
0.170
Why?
Acupressure
1
2009
15
0.170
Why?
Drug Resistance, Neoplasm
1
2009
56
0.170
Why?
Adrenal Gland Neoplasms
1
2009
36
0.170
Why?
Cell Hypoxia
1
2009
89
0.170
Why?
Pilot Projects
1
2010
446
0.170
Why?
Prospective Studies
2
2001
1696
0.160
Why?
Infusions, Intravenous
1
2008
143
0.160
Why?
Quinuclidines
1
2007
6
0.160
Why?
Kinetics
2
1988
1471
0.160
Why?
Smoking
2
2008
423
0.160
Why?
Muscarinic Agonists
1
2007
23
0.160
Why?
Thiophenes
1
2007
18
0.160
Why?
Cohort Studies
1
2011
984
0.150
Why?
Xerostomia
1
2007
44
0.150
Why?
Hematopoietic Stem Cells
1
2009
200
0.150
Why?
Bisbenzimidazole
3
1988
9
0.150
Why?
Antigens, Differentiation, B-Lymphocyte
2
2003
51
0.150
Why?
Dictionaries as Topic
1
2006
1
0.140
Why?
Reproducibility of Results
1
2010
903
0.140
Why?
Radiation-Protective Agents
1
2006
41
0.140
Why?
Lung
2
1988
1148
0.130
Why?
New York
1
2010
1378
0.130
Why?
Age Factors
1
2009
1152
0.130
Why?
Spectroscopy, Near-Infrared
1
2005
12
0.130
Why?
Antigens, CD
2
2003
254
0.130
Why?
Terminology as Topic
1
2006
108
0.130
Why?
History, 21st Century
1
2005
48
0.130
Why?
ROC Curve
1
2005
130
0.130
Why?
Cell Differentiation
1
2011
1127
0.130
Why?
Intestines
1
2005
153
0.120
Why?
Apoptosis
3
2003
855
0.120
Why?
Research
1
2005
185
0.120
Why?
Anoxia
1
2005
159
0.120
Why?
History, 20th Century
1
2005
245
0.120
Why?
Information Services
1
2003
24
0.120
Why?
Maximum Tolerated Dose
1
2003
18
0.110
Why?
G2 Phase
1
2003
29
0.110
Why?
Cyclooxygenase Inhibitors
1
2003
66
0.110
Why?
Predictive Value of Tests
1
2005
609
0.110
Why?
United States
1
2011
2847
0.110
Why?
Sulfonamides
1
2003
103
0.110
Why?
Surgical Procedures, Operative
1
2003
116
0.110
Why?
Models, Biological
1
2007
1029
0.100
Why?
Transplantation, Heterologous
1
2001
96
0.100
Why?
Necrosis
1
2001
103
0.100
Why?
Neoplasm Transplantation
1
2001
189
0.100
Why?
Mesothelioma
1
2001
28
0.100
Why?
Postoperative Complications
1
2006
764
0.100
Why?
Isoenzymes
1
2003
448
0.090
Why?
Risk Factors
2
2002
2331
0.090
Why?
Transplantation Conditioning
1
1999
36
0.090
Why?
Prognosis
1
2003
1078
0.090
Why?
Cyclophosphamide
1
1999
177
0.080
Why?
Fibroblast Growth Factor 2
1
1999
85
0.080
Why?
Bone Marrow Transplantation
1
1999
201
0.080
Why?
Dose-Response Relationship, Drug
2
1990
1142
0.070
Why?
Comorbidity
2
2008
377
0.070
Why?
Breast Neoplasms
1
2003
666
0.070
Why?
Transplantation, Homologous
2
1999
280
0.070
Why?
Ethidium
1
1994
15
0.060
Why?
Receptors, Transferrin
2
2003
21
0.060
Why?
Staining and Labeling
2
1990
170
0.060
Why?
Platelet Count
1
2012
52
0.050
Why?
Tissue Survival
1
1992
5
0.050
Why?
Phosphocreatine
1
1992
13
0.050
Why?
Organophosphorus Compounds
1
1992
25
0.050
Why?
Hydrogen
1
1992
30
0.050
Why?
Transplantation, Autologous
1
2012
151
0.050
Why?
Fatal Outcome
1
2012
109
0.050
Why?
Models, Anatomic
1
1992
39
0.050
Why?
Phosphorus
1
1992
50
0.050
Why?
Intention to Treat Analysis
1
2011
10
0.050
Why?
Drug Toxicity
1
2011
17
0.050
Why?
Cell Separation
2
1988
230
0.050
Why?
BH3 Interacting Domain Death Agonist Protein
1
2011
12
0.050
Why?
Phosphates
1
1992
152
0.050
Why?
Ischemia
1
1992
91
0.050
Why?
Rats, Inbred F344
1
1992
363
0.050
Why?
Diploidy
1
1990
14
0.050
Why?
bcl-2-Associated X Protein
1
2011
55
0.050
Why?
bcl-X Protein
1
2011
41
0.050
Why?
Rats, Inbred Strains
1
1992
654
0.050
Why?
Erythroblasts
1
2011
38
0.050
Why?
Weight Loss
1
2011
79
0.050
Why?
Equipment Design
1
1992
253
0.050
Why?
Mitogens
1
1990
36
0.050
Why?
Surgical Flaps
1
1992
120
0.050
Why?
Neoplasm Metastasis
1
2011
229
0.050
Why?
Rats
2
1992
4389
0.050
Why?
Image Enhancement
1
1992
148
0.050
Why?
Cell Count
1
1990
287
0.050
Why?
Transferrin
1
1989
38
0.040
Why?
Etoposide
1
2009
83
0.040
Why?
Markov Chains
1
2009
40
0.040
Why?
Cell Communication
1
1990
140
0.040
Why?
Tumor Burden
1
2009
22
0.040
Why?
Recurrence
1
2011
697
0.040
Why?
Gastrointestinal Tract
1
2009
26
0.040
Why?
Cell Division
3
1988
773
0.040
Why?
Fluorescent Dyes
1
1990
235
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
543
0.040
Why?
Vomiting
1
2009
116
0.040
Why?
Dexamethasone
1
1989
188
0.040
Why?
Benzimidazoles
1
1988
23
0.040
Why?
Biopsy
1
1989
384
0.040
Why?
Dyspepsia
1
2007
2
0.040
Why?
Sweat
1
2007
6
0.040
Why?
Diarrhea
1
2007
65
0.040
Why?
Pulmonary Fibrosis
1
1988
139
0.040
Why?
Insulin
1
1990
670
0.040
Why?
Logistic Models
1
2009
626
0.040
Why?
Incidence
1
2008
682
0.030
Why?
Transforming Growth Factor beta2
1
2005
4
0.030
Why?
Transforming Growth Factor beta3
1
2005
4
0.030
Why?
Algorithms
1
2009
543
0.030
Why?
Kidney
1
2009
589
0.030
Why?
Mice, Inbred DBA
1
2005
92
0.030
Why?
Risk Assessment
1
2009
875
0.030
Why?
Gene Expression Regulation
1
2011
895
0.030
Why?
Transforming Growth Factor beta1
1
2005
78
0.030
Why?
DNA
1
1990
862
0.030
Why?
Propidium
1
2004
4
0.030
Why?
Young Adult
1
2009
1084
0.030
Why?
Cytogenetic Analysis
1
2004
21
0.030
Why?
Splenic Diseases
1
2003
15
0.030
Why?
Splenectomy
1
2003
39
0.030
Why?
Antimetabolites, Antineoplastic
1
2004
40
0.030
Why?
Pregnancy
1
1989
1941
0.030
Why?
Drug Screening Assays, Antitumor
1
2003
37
0.030
Why?
Fluorouracil
1
2004
78
0.030
Why?
Xenograft Model Antitumor Assays
1
2003
46
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2003
62
0.030
Why?
Interferon-gamma
1
2005
341
0.030
Why?
Transforming Growth Factor beta
1
2005
411
0.030
Why?
Cyclooxygenase 2
1
2003
230
0.030
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
170
0.030
Why?
Rats, Sprague-Dawley
1
2004
1036
0.020
Why?
Membrane Proteins
1
2003
560
0.020
Why?
RNA, Messenger
1
2005
1893
0.020
Why?
Data Display
1
1990
13
0.010
Why?
Reference Standards
1
1990
45
0.010
Why?
Fluorescence
1
1990
74
0.010
Why?
Microcomputers
1
1988
10
0.010
Why?
Fluorescent Antibody Technique
1
1988
307
0.010
Why?
Lymphocytes
1
1988
298
0.010
Why?
Lymphocyte Activation
1
1988
414
0.010
Why?

Visualizations


Chen's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department